Wouter Korver
22Patents
6h-index
25Co-inventors
65Inventor score
Filing activity: May 23, 2005 → Aug 31, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8362211B2 | Anti-CD38 antibodies | Chemistry; Metallurgy | 15 | Active |
| US8536310B2 | Antibodies to CLL-1 | Chemistry; Metallurgy | 9 | Active |
| US9102744B2 | Conjugated anti-CD38 antibodies | Chemistry; Metallurgy | 9 | Active |
| US9676869B2 | Conjugated anti-CD38 antibodies | Chemistry; Metallurgy | 7 | Active |
| US8926969B2 | Anti-CD38 antibodies | Chemistry; Metallurgy | 7 | Active |
| US9790285B2 | Anti-CD38 antibodies | Chemistry; Metallurgy | 6 | Active |
| US10494444B2 | Anti-CD38 antibodies | Chemistry; Metallurgy | 5 | Active |
| US9611322B2 | Fusions of antibodies to CD38 and attenuated interferon alpha | Chemistry; Metallurgy | 5 | Active |
| US10336833B2 | Conjugated anti-CD38 antibodies | Chemistry; Metallurgy | 5 | Active |
| US7847067B2 | Antibodies to NTB-A | Chemistry; Metallurgy | 4 | Active |
| US11414496B2 | Anti-CD38 binding domains | Chemistry; Metallurgy | 3 | Active |
| US7625549B2 | Determining the risk of human anti-human antibodies in transgenic mice | Chemistry; Metallurgy | 2 | Expired |
| US11773162B2 | Anti-Siglec-7 antibodies for the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US10981986B2 | Fusions of antibodies to CD38 and attenuated interferon alpha | Chemistry; Metallurgy | 1 | Active |
| US8193320B2 | Antibodies to NTB-A | Chemistry; Metallurgy | 1 | Active |
| US8198508B2 | Reducing the risk of human anti-human antibodies through V gene manipulation | Chemistry; Metallurgy | 1 | Active |
| US11434304B2 | Anti-CD38 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11912766B2 | Anti-Siglec-7 antibodies having reduced effector function | Chemistry; Metallurgy | 0 | Active |
| US8993726B2 | Antibodies to NTB-A | Chemistry; Metallurgy | 0 | Active |
| US12312411B2 | Anti-CD38 binding domains | Chemistry; Metallurgy | 0 | Active |
| US8597615B2 | Methods of monitoring a human anti-human antibody response and inhibitors thereof | Chemistry; Metallurgy | 0 | Active |
| US12209138B2 | Anti-CD38 antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.